$MD
Pediatrix Medical Group, Inc.

2019 Q2 Form 10-Q Financial Statement

#000119312519135054 Filed on May 02, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q4
Revenue $561.2M $851.2M $932.7M
YoY Change -38.73% -5.62% 2.4%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $445.4M $451.9M -$736.8M
YoY Change -35.82% -35.96% -226.01%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.600M $20.03M $29.89M
YoY Change -71.34% 0.6% 13.16%
% of Gross Profit
Operating Expenses $484.0M $772.7M $829.1M
YoY Change -38.52% 2.62% 5.6%
Operating Profit $78.46M $103.6M
YoY Change -21.28% -17.6%
Interest Expense -$27.90M $30.72M $25.45M
YoY Change -229.14% 54.12% 28.24%
% of Operating Profit 39.16% 24.57%
Other Income/Expense, Net -$27.84M -$22.20M
YoY Change 64.38% 27.9%
Pretax Income $31.50M $50.62M $81.37M
YoY Change -71.24% -38.82% -24.9%
Income Tax $11.50M $8.962M $21.16M
% Of Pretax Income 36.51% 17.71% 26.0%
Net Earnings -$8.200M -$242.9M $60.21M
YoY Change -110.33% -482.91% -55.76%
Net Earnings / Revenue -1.46% -28.53% 6.46%
Basic Earnings Per Share -$2.82 $0.69
Diluted Earnings Per Share -$98.56K -$2.81 $0.68
COMMON SHARES
Basic Shares Outstanding 86.54M 86.07M 87.81M shares
Diluted Shares Outstanding 83.69M 86.55M 88.26M

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.3M $112.7M $47.40M
YoY Change 123.54% 117.57% -32.77%
Cash & Equivalents $24.50M $26.48M $40.77M
Short-Term Investments $82.80M $86.20M $21.90M
Other Short-Term Assets $374.0M $16.68M $17.17M
YoY Change 2529.54% 0.53% -53.81%
Inventory
Prepaid Expenses $12.86M $17.12M
Receivables $504.2M $522.6M $506.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $985.5M $1.057B $660.0M
YoY Change 57.7% 69.82% 5.22%
LONG-TERM ASSETS
Property, Plant & Equipment $182.6M $89.04M $90.43M
YoY Change 38.42% -29.92% -26.8%
Goodwill $4.066B $4.061B
YoY Change -5.49% -5.19%
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $69.70M
YoY Change -100.0% -100.0% -13.63%
Other Assets $115.0M $102.7M $103.1M
YoY Change 24.14% 11.3% 12.18%
Total Long-Term Assets $4.653B $4.649B $5.278B
YoY Change -11.11% -11.63% 0.71%
TOTAL ASSETS
Total Short-Term Assets $985.5M $1.057B $660.0M
Total Long-Term Assets $4.653B $4.649B $5.278B
Total Assets $5.639B $5.706B $5.937B
YoY Change -3.77% -3.01% 1.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.40M $32.15M $31.06M
YoY Change 14.18% 1.55% -10.32%
Accrued Expenses $378.5M $305.5M $417.5M
YoY Change 14.73% 12.77% 3.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $200.0K $300.0K
YoY Change -77.78% -81.82% -78.57%
Total Short-Term Liabilities $441.0M $415.2M $502.8M
YoY Change 7.24% 16.3% -5.39%
LONG-TERM LIABILITIES
Long-Term Debt $2.080B $2.120B $1.974B
YoY Change 9.98% 7.85% 6.64%
Other Long-Term Liabilities $308.2M $21.58M $31.83M
YoY Change 751.4% -61.82% -45.03%
Total Long-Term Liabilities $2.388B $21.58M $31.83M
YoY Change 6497.14% -61.82% -45.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $441.0M $415.2M $502.8M
Total Long-Term Liabilities $2.388B $21.58M $31.83M
Total Liabilities $2.914B $2.926B $2.850B
YoY Change 9.02% 6.82% 1.74%
SHAREHOLDERS EQUITY
Retained Earnings $1.801B $2.094B
YoY Change -14.7% 2.25%
Common Stock $978.7M $993.5M
YoY Change -5.15% -2.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.725B $2.780B $3.088B
YoY Change
Total Liabilities & Shareholders Equity $5.639B $5.706B $5.937B
YoY Change -3.77% -3.01% 1.2%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$8.200M -$242.9M $60.21M
YoY Change -110.33% -482.91% -55.76%
Depreciation, Depletion And Amortization $7.600M $20.03M $29.89M
YoY Change -71.34% 0.6% 13.16%
Cash From Operating Activities $131.4M -$56.82M $163.8M
YoY Change -3.52% -50.0% -9.9%
INVESTING ACTIVITIES
Capital Expenditures -$10.10M -$5.800M $7.700M
YoY Change 3.06% -31.76% 32.76%
Acquisitions $4.250M
YoY Change -80.66%
Other Investing Activities -$8.800M -$2.900M -$102.6M
YoY Change 25.71% -78.83% -47.38%
Cash From Investing Activities -$18.90M -$8.691M -$95.00M
YoY Change 12.5% -60.81% -49.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $76.11M
YoY Change 1939.83%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -107.1M 66.66M -30.30M
YoY Change -11.71% -42.8% -219.76%
NET CHANGE
Cash From Operating Activities 131.4M -56.82M 163.8M
Cash From Investing Activities -18.90M -8.691M -95.00M
Cash From Financing Activities -107.1M 66.66M -30.30M
Net Change In Cash 5.400M 1.156M 38.50M
YoY Change -384.21% -106.0% 113.89%
FREE CASH FLOW
Cash From Operating Activities $131.4M -$56.82M $163.8M
Capital Expenditures -$10.10M -$5.800M $7.700M
Free Cash Flow $141.5M -$51.02M $156.1M
YoY Change -3.08% -51.47% -11.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 md Percentage Of Net Patient Service Revenue By Type Of Payor
PercentageOfNetPatientServiceRevenueByTypeOfPayor
1.00
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15915000
CY2019Q1 md Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Discontinued Operations Ending Balance
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDiscontinuedOperationsEndingBalance
-11425000
CY2019Q1 us-gaap Short Term Investments
ShortTermInvestments
0
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
864000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
878000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
977872000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
992647000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1801270000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2094359000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
2779812000
CY2019Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
392000000
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
739500000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
522638000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
506723000
CY2019Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12862000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17123000
CY2019Q1 us-gaap Other Assets Current
OtherAssetsCurrent
16680000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17166000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
1057416000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
659977000
CY2018Q4 md Accounts Payable And Accrued Liabilities Excluding Accrued Income Taxes Current
AccountsPayableAndAccruedLiabilitiesExcludingAccruedIncomeTaxesCurrent
448567000
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
44971000
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
30598000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
415183000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
502762000
CY2018Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11000000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86073000
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92859000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
472000
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
646000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86545000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93505000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
504000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26476000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25491000
CY2019Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
20000000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
20000000
CY2019Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
86223000
CY2018Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
21923000
CY2018Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
69699000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89037000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
90434000
CY2019Q1 us-gaap Goodwill
Goodwill
4065506000
CY2018Q4 us-gaap Goodwill
Goodwill
4061439000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
300662000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
313165000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
102653000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103134000
CY2019Q1 us-gaap Assets
Assets
5706257000
CY2018Q4 us-gaap Assets
Assets
5937481000
CY2019Q1 md Accounts Payable And Accrued Liabilities Excluding Accrued Income Taxes Current
AccountsPayableAndAccruedLiabilitiesExcludingAccruedIncomeTaxesCurrent
312957000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31828000
CY2019Q1 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
208564000
CY2018Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
209060000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21581000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
3087884000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5706257000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5937481000
CY2019Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
90473000
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
95581000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
90983000
CY2019Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
240000
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
253000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24726000
CY2019Q1 md Long Term Debt And Capital Lease Obligations Excluding Long Term Line Of Credit
LongTermDebtAndCapitalLeaseObligationsExcludingLongTermLineOfCredit
1727482000
CY2018Q4 md Long Term Debt And Capital Lease Obligations Excluding Long Term Line Of Credit
LongTermDebtAndCapitalLeaseObligationsExcludingLongTermLineOfCredit
1234781000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71162000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-194000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86387000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87820000
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86387000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87820000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
90983000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24726000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71162000
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2019Q1 md Practice Salaries And Benefits
PracticeSalariesAndBenefits
621539000
CY2018Q1 md Practice Salaries And Benefits
PracticeSalariesAndBenefits
603955000
CY2019Q1 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
25791000
CY2018Q1 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
27403000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
101821000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
101693000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
772728000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
752965000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
78455000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
99663000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
38444000
CY2019Q1 us-gaap Interest Payable Current
InterestPayableCurrent
26516000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4790000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
9477000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16936000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10989000
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1647000
CY2018Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1474000
CY2019Q1 us-gaap Interest Expense
InterestExpense
30723000
CY2018Q1 us-gaap Interest Expense
InterestExpense
19935000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1236000
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1525000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27840000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50615000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
82727000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8962000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22720000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.82
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.81
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86073000
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92859000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86545000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93505000
CY2018 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
250000000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
32149000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31059000
CY2019Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
105565000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
242888000
CY2019Q1 md Accrued Payroll Taxes And Benefits Current
AccruedPayrollTaxesAndBenefitsCurrent
52385000
CY2018Q4 md Accrued Payroll Taxes And Benefits Current
AccruedPayrollTaxesAndBenefitsCurrent
78415000
CY2019Q1 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
41198000
CY2018Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
34931000
CY2019Q1 md Accrued Contingent Consideration Liability Current
AccruedContingentConsiderationLiabilityCurrent
15069000
CY2018Q4 md Accrued Contingent Consideration Liability Current
AccruedContingentConsiderationLiabilityCurrent
18760000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
40075000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33037000
CY2019Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
312957000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
448567000
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
3544000
CY2019Q1 md Increase Decrease In Accrued Payroll Taxes And Benefits
IncreaseDecreaseInAccruedPayrollTaxesAndBenefits
137300000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3087884000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-242872000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3542000
CY2019Q1 md Stock Issued During Period Value Stock Swaps
StockIssuedDuringPeriodValueStockSwaps
-666000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11100000
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
78982000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-194000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2779812000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-242872000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
63428000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20033000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19914000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1520000
CY2018Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1089000
CY2018Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-38785000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-634000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
21923000
CY2018Q4 md Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
21858000
CY2019Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
42000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9686000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5108000
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-399000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2767000
CY2018Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1216000
CY2019Q1 us-gaap Long Term Investments
LongTermInvestments
0
CY2019Q1 md Long Term Investments Fair Value Disclosure
LongTermInvestmentsFairValueDisclosure
0
CY2019Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1308000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
852628000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-9580000
CY2018Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
486000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-132559000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-129185000
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
14373000
CY2018Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
65000
CY2019Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-496000
CY2018Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-643000
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-11993000
CY2018Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1016000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-60408000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-116877000
CY2019Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4250000
CY2018Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21975000
CY2018Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14039000
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4800000
CY2018Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
3500000
CY2019Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
5821000
CY2018Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
8463000
CY2018Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
22764000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5271000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18213000
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
518500000
CY2018Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
506000000
CY2019Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
866000000
CY2018Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
392500000
CY2019Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
500000000
CY2019Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
8380000
CY2018Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
367000
CY2019Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
42000
CY2018Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
308000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2876000
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3731000
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
78982000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
66664000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
116556000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1156000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19261000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56745000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80200000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46476000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47823000
CY2019Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
4300000
CY2019Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1966918000
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1993395000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1444280000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1486672000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
522638000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
506723000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
851183000
CY2019Q1 md Percentage Of Net Patient Service Revenue By Type Of Payor
PercentageOfNetPatientServiceRevenueByTypeOfPayor
1.00
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
69699000
CY2018Q4 md Long Term Investments Fair Value Disclosure
LongTermInvestmentsFairValueDisclosure
69090000
CY2019Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
86223000
CY2019Q1 md Disposal Group Including Discontinued Operation Cost Of Service Supplies And Other Operating Expenses
DisposalGroupIncludingDiscontinuedOperationCostOfServiceSuppliesAndOtherOperatingExpenses
5567000
CY2018Q1 md Disposal Group Including Discontinued Operation Cost Of Service Supplies And Other Operating Expenses
DisposalGroupIncludingDiscontinuedOperationCostOfServiceSuppliesAndOtherOperatingExpenses
5969000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
11023000
CY2018Q1 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
11226000
CY2018Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
3243000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
7262000
CY2019Q1 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
CY2018Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
21923000
CY2018Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
69699000
CY2018Q1 us-gaap Restructuring Charges
RestructuringCharges
0
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9700000
CY2018Q1 md Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Discontinued Operations Ending Balance
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDiscontinuedOperationsEndingBalance
-13116000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
51222000
CY2018Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
56089000
CY2019Q1 md Disposal Group Including Discontinued Operation Cost Of Salaries And Benefits
DisposalGroupIncludingDiscontinuedOperationCostOfSalariesAndBenefits
25928000
CY2018Q1 md Disposal Group Including Discontinued Operation Cost Of Salaries And Benefits
DisposalGroupIncludingDiscontinuedOperationCostOfSalariesAndBenefits
27876000
CY2018Q1 us-gaap Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
6249000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56817000
CY2019Q1 md Disposal Group Including Discontinued Operation Transaction Costs
DisposalGroupIncludingDiscontinuedOperationTransactionCosts
1100000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-113634000
CY2019Q1 md Disposal Group Including Discontinued Operation Gain Or Loss On Assets Held For Sale
DisposalGroupIncludingDiscontinuedOperationGainOrLossOnAssetsHeldForSale
-321556000
CY2019Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
3591000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
372436000
CY2018Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
51320000
CY2018Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
4769000
CY2018Q1 us-gaap Disposal Group Including Discontinued Operation Other Expense
DisposalGroupIncludingDiscontinuedOperationOtherExpense
9000
CY2019Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-321230000
CY2018Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
4760000
CY2019Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-36705000
CY2018Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
1339000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-284525000
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
3421000
CY2019Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
285000000
CY2019Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
372537000
CY2018Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
51551000
CY2019Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
32289000
CY2018Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
23344000
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.48
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.65
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.48
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.64
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-3.31
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.04
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-3.29
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.04
CY2019Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-3420000
CY2018Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-3963000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8691000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22176000
CY2018Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-7000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
66664000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
116549000
CY2019Q1 md Number Of Neonatology Practices Acquired
NumberOfNeonatologyPracticesAcquired
1
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
MEDNAX, INC.
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000893949
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
MD
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q1 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
0
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2019Q1 us-gaap Liabilities
Liabilities
2926445000
CY2018Q4 us-gaap Liabilities
Liabilities
2849597000
CY2019Q1 us-gaap Lease Cost
LeaseCost
9998000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
86537633
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
19417000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
24418000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20331000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
15731000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
11694000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
14636000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
106227000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24726000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71162000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
7643000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
722000
CY2019Q1 md Operating Leases Other Costs
OperatingLeasesOtherCosts
1633000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-321214000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Other Expense
DisposalGroupIncludingDiscontinuedOperationOtherExpense
16000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3066454000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
63428000
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4027000
CY2018Q1 md Stock Issued During Period Value Stock Swaps
StockIssuedDuringPeriodValueStockSwaps
-296000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9875000
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3143488000
CY2019Q1 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
1400000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-284525000
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
3421000
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
41653000
CY2018Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
60007000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-242872000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
63428000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-284525000
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
3421000
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
639633000
CY2018Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
36085000
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
42603000
CY2019Q1 md Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset
DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset
4843000
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
321600000
CY2019Q1 md Incremental Non Cash Charge On Goodwill
IncrementalNonCashChargeOnGoodwill
36600000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0
CY2019Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2019Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
0
CY2019Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
11425000
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
11254000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
39619000
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
38118000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
2741000
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
2505000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
43440000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
0
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
321556000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Current
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent
270469000
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Current
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent
275148000
CY2019Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
372537000
CY2018Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
691184000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
23896000
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
23770000
CY2019Q1 md Disposal Group Including Discontinued Operation Lease Liabilities
DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities
7231000
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Deferred Tax Liabilities Current
DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilitiesCurrent
1163000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
10648000
CY2019Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
36600000
CY2019Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
32290000
CY2018Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
59429000
CY2018Q4 us-gaap Disposal Group Including Discontinued Operation Deferred Tax Liabilities Current
DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilitiesCurrent
35659000
CY2019Q1 md Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
0
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10339000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
95888000

Files In Submission

Name View Source Status
0001193125-19-135054-index-headers.html Edgar Link pending
0001193125-19-135054-index.html Edgar Link pending
0001193125-19-135054.txt Edgar Link pending
0001193125-19-135054-xbrl.zip Edgar Link pending
d709210d10q.htm Edgar Link pending
d709210dex101.htm Edgar Link pending
d709210dex102.htm Edgar Link pending
d709210dex311.htm Edgar Link pending
d709210dex312.htm Edgar Link pending
d709210dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
md-20190331.xml Edgar Link completed
md-20190331.xsd Edgar Link pending
md-20190331_cal.xml Edgar Link unprocessable
md-20190331_def.xml Edgar Link unprocessable
md-20190331_lab.xml Edgar Link unprocessable
md-20190331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending